FOLH1 and neoplasm: Normal prostate tissue does not show membrane expression of the PSMA epitope [21], but depending on the [177Lu]Lu-PSMA-617 activity level, an estimated dose of 94–113 Gy EQD2 may be delivered to index tumour lesions.